Geode Capital Management, LLC Inmune Bio, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 344,466 shares of INMB stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

344,466

Previous 323,204 6.58%

Holding current value

$1.68 Million

Previous $2.85 Million 34.88%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.86 - $9.86 $103,333 - $209,643	21,262 Added 6.58%	344,466 $1.86 Million
Q2 2024 Aug 09, 2024	BUY	$7.15 - $11.84 $1.09 Million - $1.8 Million	152,402 Added 89.23%	323,204 $2.85 Million
Q1 2024 May 13, 2024	BUY	$10.53 - $14.01 $8,023 - $10,675	762 Added 0.45%	170,802 $2.01 Million
Q4 2023 Feb 13, 2024	BUY	$6.6 - $11.52 $19,384 - $33,834	2,937 Added 1.76%	170,040 $1.91 Million
Q3 2023 Nov 13, 2023	BUY	$6.61 - $10.9 $82,116 - $135,410	12,423 Added 8.03%	167,103 $1.13 Million
Q2 2023 Aug 11, 2023	BUY	$6.5 - $10.09 $71,649 - $111,222	11,023 Added 7.67%	154,680 $1.4 Million
Q1 2023 May 15, 2023	BUY	$6.01 - $10.18 $3,966 - $6,718	660 Added 0.46%	143,657 $928,000
Q4 2022 Feb 13, 2023	BUY	$6.13 - $7.96 $20,786 - $26,992	3,391 Added 2.43%	142,997 $906,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $10.44 $8,347 - $14,428	1,382 Added 1.0%	139,606 $865,000
Q2 2022 Aug 12, 2022	BUY	$5.48 - $8.97 $58,608 - $95,934	10,695 Added 8.39%	138,224 $1.22 Million
Q1 2022 May 13, 2022	BUY	$6.42 - $11.39 $59,442 - $105,460	9,259 Added 7.83%	127,529 $1.07 Million
Q4 2021 Feb 11, 2022	BUY	$9.97 - $20.38 $285,770 - $584,151	28,663 Added 31.99%	118,270 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$14.13 - $27.85 $223,437 - $440,392	15,813 Added 21.43%	89,607 $1.74 Million
Q2 2021 Aug 13, 2021	BUY	$9.29 - $19.33 $120,370 - $250,458	12,957 Added 21.3%	73,794 $1.3 Million
Q1 2021 May 12, 2021	BUY	$11.61 - $26.85 $315,583 - $729,836	27,182 Added 80.77%	60,837 $722,000
Q4 2020 Feb 12, 2021	BUY	$7.51 - $17.22 $27,276 - $62,543	3,632 Added 12.1%	33,655 $579,000
Q3 2020 Nov 13, 2020	BUY	$4.92 - $15.75 $147,713 - $472,862	30,023 New	30,023 $309,000

Others Institutions Holding INMB

# of Institutions

Shares Held

5.9M

Call Options Held

243K

Put Options Held

46.4K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $87.4M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Inmune Bio, Inc. Transaction History